Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt No Debt
NAS:SKLN's Cash to Debt is ranked higher than
85% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. NAS:SKLN: No Debt )
Ranked among companies with meaningful Cash to Debt only.
NAS:SKLN' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.21 Max: No Debt
Current: No Debt
Equity to Asset 0.01
NAS:SKLN's Equity to Asset is ranked lower than
94% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. NAS:SKLN: 0.01 )
Ranked among companies with meaningful Equity to Asset only.
NAS:SKLN' s Equity to Asset Range Over the Past 10 Years
Min: -9.72  Med: -5.22 Max: 0.73
Current: 0.01
-9.72
0.73
F-Score: 3
Z-Score: -42.07
M-Score: -2.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -1612.00
NAS:SKLN's Operating margin (%) is ranked lower than
95% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. NAS:SKLN: -1612.00 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:SKLN' s Operating margin (%) Range Over the Past 10 Years
Min: -18075  Med: -2847.92 Max: -672.78
Current: -1612
-18075
-672.78
Net-margin (%) -1611.20
NAS:SKLN's Net-margin (%) is ranked lower than
95% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. NAS:SKLN: -1611.20 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:SKLN' s Net-margin (%) Range Over the Past 10 Years
Min: -18075  Med: -2968.41 Max: -717.86
Current: -1611.2
-18075
-717.86
ROE (%) -303.89
NAS:SKLN's ROE (%) is ranked lower than
98% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. NAS:SKLN: -303.89 )
Ranked among companies with meaningful ROE (%) only.
NAS:SKLN' s ROE (%) Range Over the Past 10 Years
Min: -303.89  Med: 0 Max: 0
Current: -303.89
-303.89
0
ROA (%) -175.81
NAS:SKLN's ROA (%) is ranked lower than
99% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. NAS:SKLN: -175.81 )
Ranked among companies with meaningful ROA (%) only.
NAS:SKLN' s ROA (%) Range Over the Past 10 Years
Min: -1953.48  Med: -754.14 Max: -146.67
Current: -175.81
-1953.48
-146.67
ROC (Joel Greenblatt) (%) -6326.53
NAS:SKLN's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. NAS:SKLN: -6326.53 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:SKLN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -159177.78  Med: -14508.34 Max: -2619.05
Current: -6326.53
-159177.78
-2619.05
Revenue Growth (3Y)(%) -6.20
NAS:SKLN's Revenue Growth (3Y)(%) is ranked lower than
77% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. NAS:SKLN: -6.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:SKLN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -6.2 Max: 16.9
Current: -6.2
0
16.9
EBITDA Growth (3Y)(%) -47.60
NAS:SKLN's EBITDA Growth (3Y)(%) is ranked lower than
95% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. NAS:SKLN: -47.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NAS:SKLN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.6  Med: -30.5 Max: -14.8
Current: -47.6
-47.6
-14.8
EPS Growth (3Y)(%) -47.00
NAS:SKLN's EPS Growth (3Y)(%) is ranked lower than
94% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. NAS:SKLN: -47.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:SKLN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -47  Med: -29.2 Max: -17.5
Current: -47
-47
-17.5
» NAS:SKLN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with SKLN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:BMRA, OTCPK:REPR, NAS:PDEX, OTCBB:NEPH, OTCPK:STXS, NAS:BLFS, NAS:DXTR, NAS:AKER, OTCPK:SOAN, NAS:NURO, NAS:SSKN, OTCPK:WHSI, OTCPK:REMI, OTCPK:PEYE, OTCPK:VPTDF, OTCPK:ECIA, OTCPK:IRSB, AMEX:DXR, OTCPK:ASNB, AMEX:ISR » details
Skyline Medical Inc is an development stage company that manufactures and sells environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care.

Skyline Medical Inc, formerly known as BioDrain Medical Inc., was incorporated on April 23, 2002. The Company is a development stage medical device company manufacturing a system for the collection and disposal of infectious fluids that results from surgical procedures and post-operative care. The Company owns patent rights to products and distributes products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed. Its products minimize the exposure potential to the healthcare workers who handles such fluids. Its product, the STREAMWAY Fluid Management System, suctions surgical waste fluid from the patient using standard surgical tubing. The surgical waste fluid passes through disposable filters and into the STREAMWAY System. The STREAMWAY System maintains continuous suction to the surgical field. This simplifies the handling of fluids and will provide cost savings to facilities over the aggregate costs incurred using the traditional canister method of collection, neutralization and disposal. It sells its products through in-house sales force and intends to utilize independent distributors and manufacturer's representatives in the United States and Europe, initially, and eventually internationally. The Company competes with Cardinal Health, Inc. as well as Stryker Corporation, among others.

Ratios

vs
industry
vs
history
P/B 1036.75
SKLN's P/B is ranked lower than
100% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.12 vs. SKLN: 1036.75 )
Ranked among companies with meaningful P/B only.
SKLN' s P/B Range Over the Past 10 Years
Min: 1.36  Med: 4.41 Max: 1666.67
Current: 1036.75
1.36
1666.67
P/S 2.25
SKLN's P/S is ranked lower than
51% of the 222 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.98 vs. SKLN: 2.25 )
Ranked among companies with meaningful P/S only.
SKLN' s P/S Range Over the Past 10 Years
Min: 0.96  Med: 22.14 Max: 5501.62
Current: 2.25
0.96
5501.62
EV-to-EBIT -1.33
SKLN's EV-to-EBIT is ranked lower than
99.99% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.14 vs. SKLN: -1.33 )
Ranked among companies with meaningful EV-to-EBIT only.
SKLN' s EV-to-EBIT Range Over the Past 10 Years
Min: -20.6  Med: -2.3 Max: 0.2
Current: -1.33
-20.6
0.2
EV-to-EBITDA -1.33
SKLN's EV-to-EBITDA is ranked lower than
99.99% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. SKLN: -1.33 )
Ranked among companies with meaningful EV-to-EBITDA only.
SKLN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -20.7  Med: -2.3 Max: 0.2
Current: -1.33
-20.7
0.2
Current Ratio 1.16
SKLN's Current Ratio is ranked lower than
85% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. SKLN: 1.16 )
Ranked among companies with meaningful Current Ratio only.
SKLN' s Current Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.12 Max: 3.55
Current: 1.16
0.01
3.55
Quick Ratio 0.96
SKLN's Quick Ratio is ranked lower than
77% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. SKLN: 0.96 )
Ranked among companies with meaningful Quick Ratio only.
SKLN' s Quick Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.09 Max: 3.4
Current: 0.96
0.01
3.4
Days Inventory 375.63
SKLN's Days Inventory is ranked lower than
95% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 123.20 vs. SKLN: 375.63 )
Ranked among companies with meaningful Days Inventory only.
SKLN' s Days Inventory Range Over the Past 10 Years
Min: 231.8  Med: 319.38 Max: 375.63
Current: 375.63
231.8
375.63
Days Sales Outstanding 32.85
SKLN's Days Sales Outstanding is ranked higher than
92% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. SKLN: 32.85 )
Ranked among companies with meaningful Days Sales Outstanding only.
SKLN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.21  Med: 76.45 Max: 365
Current: 32.85
21.21
365
Days Payable 931.18
SKLN's Days Payable is ranked higher than
99% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.76 vs. SKLN: 931.18 )
Ranked among companies with meaningful Days Payable only.
SKLN' s Days Payable Range Over the Past 10 Years
Min: 780.43  Med: 2078.9 Max: 42444.29
Current: 931.18
780.43
42444.29

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -61.30
SKLN's 3-Year Average Share Buyback Ratio is ranked lower than
94% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. SKLN: -61.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SKLN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -128.9  Med: -81.7 Max: -61.3
Current: -61.3
-128.9
-61.3

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.10
SKLN's Price/Median PS Value is ranked higher than
98% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.08 vs. SKLN: 0.10 )
Ranked among companies with meaningful Price/Median PS Value only.
SKLN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.05  Med: 1.07 Max: 45.61
Current: 0.1
0.05
45.61
Earnings Yield (Greenblatt) (%) -75.76
SKLN's Earnings Yield (Greenblatt) (%) is ranked lower than
94% of the 228 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. SKLN: -75.76 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SKLN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -362.11  Med: 109.4 Max: 608.5
Current: -75.76
-362.11
608.5

More Statistics

Revenue (TTM) (Mil) $0.50
EPS (TTM) $ -16.68
Beta-0.07
Short Percentage of Float10.61%
52-Week Range $1.52 - 100.03
Shares Outstanding (Mil)3.80
» More Articles for NAS:SKLN

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
8:31 am Skyline Medical names executive chairman Dr. Carl Schwartz as CEO; in comments, co states it... Dec 03 2016
Skyline Medical Names Carl Schwartz Chief Executive Officer, Appoints Richard Gabriel to Board of... Dec 02 2016
Skyline Medical Vice President of Sales Interviewed on WPSL-AM 1590 MONEYINFO Program Dec 01 2016
Skyline Medical Announces Completion of Registered Direct Offering for Gross Proceeds of $1,983,337 Nov 30 2016
Skyline Medical Doubles on Canada Deal Nov 22 2016
Skyline Medical Receives Health Canada Approval to Market STREAMWAY® System Nov 22 2016
SKYLINE MEDICAL INC. Financials Nov 19 2016
Skyline Medical, Inc. :SKLN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Nov 18 2016
SKYLINE MEDICAL INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 15 2016
Skyline Medical Reports Third Quarter 2016 Financial Results Nov 15 2016
SKYLINE MEDICAL INC. Files SEC form 10-Q, Quarterly Report Nov 14 2016
Skyline Medical to Hold Third Quarter Financial Results Conference Call on November 15th Nov 08 2016
Skyline Medical Expands Relationship with GLG Pharma to Include Exclusive Distribution of STREAMWAY... Nov 02 2016
Skyline Medical Shares Soar After Announcing UK Distribution Deal Nov 01 2016
Skyline Medical Signs Agreement for GLG Pharma to be Exclusive Distributor of STREAMWAY System in... Nov 01 2016
Two Skyline Medical Directors along with GLG Pharma’s Chief Operating Officer to be Interviewed on... Oct 31 2016
SKYLINE MEDICAL INC. Files SEC form 8-K, Change in Directors or Principal Officers Oct 31 2016
SKYLINE MEDICAL INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Oct 27 2016
Skyline Medical Appoints J. Melville Engle and Timothy A. Krochuk to its Board of Directors Oct 27 2016
Skyline Medical Effects 1-For-25 Reverse Stock Split Oct 27 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)